Tradestie Institutional Equity Comparison Engine

NPCT vs SLSN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SLSN Overall Edge

SLSN Captures Institutional Edge (4โ€“0 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Solesence, Inc. Common Stock (SLSN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NPCT trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus SLSN at 11.4x Forward P/E and 4.5% operating margin (+38.1% YoY). In options structure, NPCT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SLSN sits in CONSOLIDATION (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner SLSN
NPCT N/M vs SLSN 11.4x Fwd P/E
Growth & Margin Winner SLSN
Op Margin N/A vs 4.5% ยท YoY N/A vs +38.1%
Momentum & Technical Winner SLSN
1Y -16.4% vs -28.1% ยท 52W Pos 3% vs 47%
Options & Structure Winner SLSN
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (N/A IV)
NPCT NYSE
Nuveen Core Plus Impact Fund
Institutional Equity
$8.68
-0.34% 1D
Market Cap $315.2M
1M Return -2.8%
1Y Return -16.38%
Forward P/E N/M
Unified AI Score
32.9 / 100 SELL
Tech 2.0 Fund 41.0 Flow 50.0 Mom 65.0
SLSN NASDAQ
Solesence, Inc. Common Stock
Perfumes, Cosmetics & Other Toilet Preparations
$1.41
-4.73% 1D
Market Cap $104.6M
1M Return +64.62%
1Y Return -28.06%
Forward P/E 11.4x
Unified AI Score
32.4 / 100 SELL
Tech 50.0 Fund 32.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NPCT -16.38% SLSN -28.06% Spread: +11.68 pp (NPCT Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NPCT TTM Op. Margin: N/A SLSN TTM Op. Margin: 4.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NPCT vs SLSN. Trailing 12-month operating profitability (NPCT N/A vs SLSN 4.5%) and valuation multiples (NPCT N/M vs SLSN 11.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NPCT (3) vs SLSN (7)
Institutional Metric NPCT SLSN Criterion Row Winner
Market Capitalization Scale $315.2M $104.6M Larger Scale NPCT
Trailing P/E Ratio Valuation N/M 49.3x Lower Multiple SLSN
Forward P/E Ratio Valuation N/M 11.4x Lower Multiple SLSN
Revenue Growth (YoY) Growth N/A +38.1% Higher Growth SLSN
Operating Margin (TTM) Profitability N/A 4.5% Higher Margin SLSN
Net Profit Margin Profitability N/A 3.0% Higher Margin SLSN
Return on Equity (ROE) Capital Efficiency N/A 10.7% Higher ROE SLSN
52-Week Range Position Momentum 3% ($9โ€“$11) 47% ($1โ€“$2) Stronger Trend SLSN
Beta / 30D Volatility Risk Regime 0.36ฮฒ ยท 13% Vol 1.49ฮฒ ยท 238% Vol Lower Realized Risk NPCT
Unified Institutional Score Composite Signal 32.9 / 100 (SELL) 32.4 / 100 (SELL) Higher Composite NPCT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NPCT vs SLSN Buy Guide
NPCT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NPCT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SLSN CONSOLIDATION
130d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SLSN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NPCT nor SLSN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.